Drug treatment of COVID-19 infection

G Lui, G Guaraldi - Current opinion in pulmonary medicine, 2023 - journals.lww.com
Drug treatment of COVID-19 infection : Current Opinion in Pulmonary Medicine Drug treatment
of COVID-19 infection : Current Opinion in Pulmonary Medicine Log in or Register Subscribe to …

Effect and safety of mesenchymal stem cells for patients with COVID‐19: Systematic review and meta‐analysis with trial sequential analysis

Z Zhang, S Shao, X Liu, Z Tong - Journal of Medical Virology, 2023 - Wiley Online Library
The objective of this study was to assess whether mesenchymal stem cells (MSCs) therapy
could offer survival advantages for patients with novel coronavirus disease 2019 (COVID …

Morbidity and mortality of hospital-onset SARS-CoV-2 infections due to Omicron versus prior variants: a propensity-matched analysis

M Klompas, CS McKenna, S Kanjilal, T Pak… - Annals of Internal …, 2024 - acpjournals.org
Background: Many hospitals have scaled back measures to prevent nosocomial SARS-CoV-
2 infection given large decreases in the morbidity and mortality of SARS-CoV-2 infections for …

Toward an Improved Electrocatalytic Determination of Immunomodulator COVID Medication Baricitinib Using Multiwalled Carbon Nanotube Nickel Hybrid

EE Abbas, AS Fayed, MA Hegazy… - ACS Applied Bio …, 2024 - ACS Publications
The study presents a first electrochemical method for the determination of the
immunomodulator drug Baricitinib (BARI), crucial in managing COVID-19 patients requiring …

A Descriptive Analysis of the Use of Various Therapeutics in a Cohort of COVID-19 Patients and the Influence of Media Coverage

AA Mathew, B Mensah, JC Cravero… - International Journal of …, 2023 - ijms.pitt.edu
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted the
healthcare system immensely throughout 2020-2022. Treatment practices varied in Texas …